Su Yon Jung

Dr. Su Yon Jung is an Associate Professor in the UCLA School of Nursing and an Adjunct Associate Professor in the Department of Epidemiology at the UCLA Fielding School of Public Health. Dr. Jung is a faulty member of the UCLA Jonsson Comprehensive Cancer Center and the Genetics & Genomics Graduate Program in Bioscience. Dr. Jung is a molecular genetic cancer epidemiologist. She completed a postdoctoral fellowship in the Department of Epidemiology at the University of Texas MD Anderson Cancer Center. During her graduate studies in Pittsburgh and later, she accumulated an array of research experiences in hospital-based metastatic breast cancer and lung cancer cohorts for cancer treatment and prognosis. Dr. Jung’s research at UCLA has focused on examining cancer-related metabolic and inflammatory biomarkers associated with lifestyle factors as cancer prevention strategies. Her current genetic and epigenetic studies evaluate the interplay of environmental/behavioral factors and genetic/epigenetic markers on molecular pathways, leading to cancer carcinogenesis and progression, which will contribute to the development of genetically/epigenetically targeted interventions.


  • PhD, Epidemiology, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA
  • MPH, Occupational Health, The Catholic University of Korea, Graduate School of Public Health, Seoul, Korea
  • BSN, Nursing Science, The Catholic University of Korea, Seoul, Korea

Areas of Interest


  • Cancer-related molecular biomarkers, particularly focusing on glucose tolerance, immune response, and inflammation.
  • Cancer genomics and epigenomics, examining the effect of interactions with lifestyle factors on cancer carcinogenesis and progression
  • Cancer health disparities, addressing the current dearth of genetic and epigenetic research in medically and scientifically underrepresented populations
  • Epidemiologic study design, data quality assurance, and machine-learning approaches for a big data; genomic/epigenetic statistics, pathway-based association, and gene-environment interaction to disentangle the complicated molecular pathways of cancer.
  • FSPH Center involvement

Selected Publications

  • Link to Publications